Psilocybin at the End of Life - Charles Grob

Psilocybin therapy helps mitigate the severe anxiety and fear of death often experienced by patients facing advanced-stage cancer. Clinical research indicates that structured administration of psilocybin, supported by thorough preparation and follow-up integration, provides significant relief and enhances the quality of life for these individuals. Historical context, including the foundational work with LSD-assisted psychotherapy, underscores the long-standing interest in using psychedelics for existential distress. Psychologists continue to explore how these non-ordinary states of consciousness facilitate deep emotional processing and provide new perspectives on mortality, emphasizing the need for compassionate, human-centered approaches to end-of-life care.